Dr. John D. Baxter, MD
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Medical school
- Pennsylvania State University College of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 37
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: Pennsylvania State University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
NJ license MA53210 · PA license MD037108E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cooper University Hospital Camden, NJ
Medical groups
- Cmc Department of Medicine Group PA (478 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 37
- Services billed
- 83
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 53 | 29 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 25 | 17 |
| Established patient office or other outpatient visit, 30-39 minutes | 23 | 12 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 22 | 22 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Biktarvy (bictegrav/emtricit/tenofov ala) | 77 |
| Triumeq (abacavir/dolutegravir/lamivudi) | 40 |
| Dovato (dolutegravir sodium/lamivudine) | 34 |
| Odefsey (emtricitab/rilpiviri/tenof ala) | 34 |
| Isentress (raltegravir potassium) | 30 |
| Descovy (emtricitabine/tenofov alafenam) | 30 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Camden, NJ | 29 |
| Juluca (dolutegravir/rilpivirine) | 26 |
| Tivicay (dolutegravir sodium) | 25 |
| Levetiracetam Other prescribers in Camden, NJ | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $10,767 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382
AbbVie Inc. · Terminated · NCT06032546 - M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of…
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.